|
More articles from Pharma Marketletter
Ligand due $1.6M from Eli Lilly for LY674.(Ligand Pharmaceuticals Inc)..., July 25, 2005
FDA OKs restart of Varisole trials.(Food and Drug Administration)(Brie..., July 25, 2005
CT's acne drug Zyflo fails in Ph II trial.(Critical Therapeutics Inc)(..., July 25, 2005
AVAX to start trials of M-Vax in cancer.(AVAX Technologies Inc.)(Brief..., July 25, 2005
CV Thera's asthma drug candidate enters Ph I.(CV Therapeutics Inc)(Bri..., July 25, 2005
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
